complicated cascade of cellular events and their coordinated interactions in vivo, are essential to control of VSMC growth and contraction. 10 - 12 The alterations in VSMC growth and contraction, which are of fundamental importance in the development of atherosclerosis and hypertension, may be due to aberrations in signal transduction processes.
Biologically active phorbol esters can mimic the effect of diacylglycerol in the activation of PK-C, 3 and since PK-C represents the major cellular phorboid receptor, 13 -15 the multitude of responses observed with cultured cells exposed to phorbol ester invoke a pivotal role for the PK-C transduction pathway in stimulus-response coupling. Observations that phorbol esters induce a slow but sustained vascular contraction in isolated arteries 16 and that angiotensin II (Ang II) induces a sustained production of diacylglycerol in VSMCs 4 have given rise to the proposal that PK-C activation may be involved in sustained agonist-induced vasoconstriction. 12 - 16 PK-C is also involved in regulating VSMC growth. 8 - 17 In this regard, we have demonstrated phorbol ester-induced activation of S6 kinase, 8 the stimulation of which is a prerequisite for cell division in quiescent cells. 18 Furthermore, phorbol ester induces activation of amiloridesensitive Na + -H + exchange, which results in elevation of intracellular pH. 19 Such alkalinization is intimately associated with both S6 kinase activation and increased proliferation in cultured VSMCs 8 -19 as well as with increased contractile tone 20 in vascular smooth muscle.
Exposure of quiescent VSMCs to Ang II also results in S6 kinase activation 8 and alkalinization. 19 Thus, these observations together with those relating to stimulation of nuclear proto-oncogene expression by Ang II in VSMCs 21 - 22 have invoked the notion that this vasoconstrictor might also be mitogenic to VSMCs. Ang II has been reported to increase both VSMC size 22 and number 23 which, in the event of exaggerated and persistent stimulation, could lead to a gradual onset of vascular hypertrophy resulting in a slow rise in peripheral vasoconstriction and arterial pressure. The blood pressurelowering effect of angiotensin converting enzyme inhibition has provided indirect evidence for a role of Ang II in the pathophysiology of hypertension. 24 Direct evidence to support such a role has been obtained from studies on cultured VSMCs from genetically hypertensive rats in which both Ang II-stimulated Ca 2+ flux and Na + -H + exchange 23 -25 were found to be enhanced relative to VSMCs from their normotensive controls. The involvement of PK-C in mediating such increased responsiveness to Ang II in VSMCs from spontaneously hypertensive rats (SHR) has not been studied. This study further investigates metabolic responsiveness to Ang II in cultured aortic VSMCs from SHR and normotensive Wistar-Kyoto (WKY) rats. PK-C levels and translocation responses were also determined in the cells, and we have attempted to evaluate the role of this enzyme in hypertension.
Materials and Methods

Materials
SHR and WKY rats (male, aged 20 weeks, and weight 200-250 g) were obtained from the inbred Wistar strain described by Okamoto and Aoki 26 and supplied via Madoerin AG, Fuellinsdorf, Switzerland. Blood pressures were measured (tail-cuff procedure) before rats were killed, and typical values (mean±SD, n=6) obtained were 215±6 mm Hg for SHR and 130±5 mm Hg for WKY rats. The chemicals and media for tissue culture were obtained from Gibco AG, Basel, Switzerland, with the exception of fetal calf serum (FCS), which was purchased from Fakola AG, Basel, Switzerland. Ail the radioisotopes and radiolabeled compounds used in this study were obtained through Rahn 27 from eight separate pairs (SHR/WKY rats) of age-matched (20 weeks) male rats. In total, 18 pairs of isolates were studied, and for any given pair the thoracic/abdominal aorta vessel sections (from the ventricular origin to the branching of the renal arteries) from which the VSMCs were isolated were carefully matched for length and location. All procedures used have been described previously.
-
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Primary cultures were routinely passaged for use in experimental regimes, and phenotypic characterization was performed as described by Jones et al. 27 Typically, for the studies herein, we used smooth muscle cells from 3rd-14th passages, during which the investigated parameters remained steady. The large number of experiments performed necessitated usage of different pairs of isolates at differing passage numbers, but for each single experiment, the cells within any pair were used at a matched passage number. Because of the differential proliferation rate of the two cell types, 7 the seeding density for WKY rat VSMCs was always twice that for SHR VSMCs such that confluency and equivalent cell numbers could be obtained with the same culture period. Cell numbers in such confluent cultures did not change during the quiescence period. Cell cultures were grown and maintained in minimal essential medium (MEM) supplemented with Earles' salts, 20 mM glutamine, 20 mM TES-NaOH, 20 mM HEPES-NaOH (both at pH 7.3), 100 units/ml penicillin, and 100 units/ml streptomycin as bacteriostatic agents, and containing 10% FCS; routine medium changes were performed every 3 days. To obtain quiescent nondividing cells, normal medium was substituted with MEM containing 0.1% wt/vol bovine serum albumin (in place of 10% FCS) and all other ingredients given above. Experiments with cultures at quiescence were performed after 48 hours incubation with serum-free medium. Cell numbers were routinely obtained by counting aliquots of cell suspensions in Isoton with a Coulter counter (Coulter Elec, Inc., Hialeah, Florida) after enzymatic disaggregation of cell layers as described already. 27 
S6 kinase activation andphosphorylation assays.
The activation of S6 kinase in quiescent cultures of SHR/WKY rat-derived cells was performed as described previously. 8 - 18 For activation, cells were incubated at 37° C for 15 minutes in freshly replaced serum-free medium without additions or with various concentrations of either Ang II, 12-0-tetradecanoylphorbol 13-acetate (TPA) or 10% FCS as positive control. Activations were terminated by rapid washing of cells with 3x2 ml aliquots of cold extraction buffer (20 mM HEPES, 15 mM MgCl 2 , 20 mM EGTA, 1 mM dithiothreiotol, and 80 mM /3-glycerol phosphate, pH 7.3), followed by scraping cell layers into 300 /xl extraction buffer containing 0.2% vol/vol Triton X-100 and 5 mM phenylmethylsulfonylfluoride. Cell lysates were collected after centrifugation for 15 minutes at ll,000g at 5° C, and samples were stored at -70° C until use. S6 kinase phosphorylation assays (specific activity of [S- 32 P] ATP at -2X10 4 disintegrations per minute (dpm)/ pmol) were performed using 40S ribosomal subunits as substrate as described previously. 8 Phosphoinositide metabolism. Confluent VSMCs were rendered quiescent and inositol lipids prelabelled to equilibrium by incubation in serum-free and inositol-free medium containing myo [2] [3] H]-inositol (5 ^.Ci/ml) for 48 hours. Thereafter, cells were washed three times with phosphate buffered saline (PBS) before addition of 1 ml isotonic PBS containing 30 mM LiCl and then preincubated for 30 minutes at 37° C. After preincubation, cells were exposed to various concentrations of Ang II for 2 minutes at 37° C. Incubations were terminated by rapid aspiration of buffer and addition of 1 ml chloroform/methanol/HCl (1:2:0.05, vol/vol/vol). 4 Dishes were maintained at 4° C for 30 minutes before collection of extracts plus a 500 ^,1 rinse. After phase separation, 4 
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- 34 A fraction of the sonicate (homogenate) was withdrawn, and the remainder was centrifuged at 100,000g for 30 minutes at 4° C. Supernatants (cytosol) were withdrawn before suspension and sonication of pellets (membranes) in PKB. All samples were stored at -70° C until use. [ 10 mM Mg(NO 3 ) 2 , 1 mM CaCV 5 -34 Bound radioactivity was quantitated and specific binding parameters determined by weighted nonlinear curve fitting analysis. 33 In translocation experiments, VSMCs were grown to confluency in 100 mm petri dishes and then rendered quiescent before exposure to TPA (10 nM) or various concentrations of Ang II for 5 minutes at 37° C. Dishes were placed on ice, aspirated with medium, and cells washed rapidly three times with PBS. Cells were harvested into 700 fil PKB, and cell fractions were prepared as described above. Quantitation of total cell protein kinase C. Confluent, quiescent VSMCs were washed with PBS before addition of 75 ti\ SDS-solubilizing buffer (10 mM Tris-HCl [pH 7.0], 3% SDS, 2% 0-mercaptoethanol, 2 mM EGTA, 2 mM EDTA, 10% glycerol) to three wells, and 1.0 ml 0.2N NaOH, 0.2% Triton-X-100 to the remaining wells. Total cell SDS extracts were transferred to Eppendorf tubes, heated at 95° C for 5 minutes and then subjected to SDS-polyacrylamide (10%) gel electrophoresis (-50-75 fig protein/slot) followed by electrophoretic transfer to nitrocellulose membranes (Bio-Rad Labs., Richmond, California). 35 Membranes were processed for immunoblotting exactly as described 36 using monoclonal antibody to PK-C (clone MC5, Amersham) and Iodine-125-labeled (0.2 /tCi/ml) sheep-anti-mouse second antibody. Clone MC5 has been reported to recognize a and /3 isoforms of PK-C. 37 Immunodetectable PK-C (M r 80 kDa) was quantitated after it was located by autoradiography, then the labelled area was excised from the membranes and counted in a Gamma counter. For comparative (SHR vs. WKY rats) purposes, all values were normalized with respect to protein loaded in each SDS-polyacrylamide gel slot. Proteins were determined in NaOH/Triton-X-100 solubilized samples by the method of Bradford 31 and with bovine serum albumin as standard.
Statistical Analysis
Unless otherwise stated values are given as mean±SD where n=number of separate experiments performed. Statistical significance was analyzed using Student's t test for unpaired data.
Results
Phosphoinositide Metabolism and Intracellular pH
To compare the efficacy of Ang II in promoting phosphoinositide breakdown in VSMCs from SHR and WKY rats, a 2-minute exposure period was found to be optimal for reproducible and accurate quantitation of dose-dependent changes in all phosphoinositides and inositol phosphate fractions. SHRderived VSMCs exhibited an amplified phosphoinositide catabolic response as evidenced by their elevated (vs. WKY rat VSMCs) accumulated levels of inositol trisphosphate and bisphosphate ( Figure  1 ). The significance of difference between SHR and WKY rat derived VSMCs reached threshold levels (/?<0.05) at 1 nM Ang II and at saturating concentrations of Ang II was/?<0.001. After a 2-minute exposure to Ang II, accumulated levels of inositol monophosphate were only slightly greater in SHRderived VSMCs (vs. WKY rat). Glycerolphosphoinositol did not accumulate in response to Ang II for VSMCs from either origin (Figure 1 ). The amplified phosphoinositide response to Ang II in SHRderived VSMCs was confirmed by their greater (/?<0.05 vs. WKY rats) loss of [ (Figure 1 ) and degradation of phosphoinositide (complete data not shown) were comparable and did not differ between SHR and WKY rat derived VSMCs (-4-8 nM). Enhanced phosphoinositide responsiveness to Ang II in SHR VSMCs was evident not only from dose-response profiles (Figure 1, 2 minutes) but also from kinetic profiles (10 M Ang II, 15 seconds to 5 minutes; compared in two paired SHR/WKY rat isolates, data not shown).
There was no difference in pHj of VSMCs from the two animal sources (SHR/WKY rats) when measured under serum-free conditions (quiescence) ( Table 1) . After stimulation by FCS (10%), TPA (100 nM), or Ang II (100 nM), significant (p at least <0.05) alkalinization was measured in both VSMC isolates, but the increase in pHi (ApH f ) was twofold greater for SHR-derived VSMCs than those from WKY rats ( Table 1) . Inclusion of Na + -H + exchange inhibitors such as amiloride (0.5 mM), dimethylamiloride (DMA) (10 yM), or ethylisopropylamiloride (EIPA, 1 fiM) completely abolished the alkalinization response of both cell types to Ang II, FCS, and TPA (pHj values ranged between 6.2 and 6.5).
The present pHj values ( 
Phorbol Ester Binding and Protein Kinase C
Estimation of PK-C by saturation analysis of [ Table 2. [ 3 H]PDBu binding parameters determined after 3 hours of incubation at 4° C were comparable with those obtained after 45 minutes at 37° C (compared in two pairs of SHR/WKY rat VSMC isolates, data not shown). Immunoblot analysis of PK-C in total cell extracts (at quiescence), using a commercial monoclonal antibody to PK-C, revealed comparable amounts of immunoreactive porypeptide (M r 80 kDa) in VSMCs from SHR (14.4±1.25 cpmJixg total protein, n=5) and WKY rats (13.3±1.38 cpm/jtg total protein, n=5). An autoradiogram indicating immunoreactive specifity of clone MC5 antibody and the comparable immunoreactivity between SHR/WKY cell extracts is given in Figure 3 . 
FIGURE 2. Binding of [ 3 H]4$-phorbol 12,13-dibutyrate (PDBu) to intact vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats (SHR) and WistarKyoto (WKY) rats. Binding of [ 3 H]PDBu to intact, quiescent VSMCs from SHR (•) and WKY rats (o) was performed as described in Materials and Methods. Values (mean of triplicate determinations) shown for nonspecific (dotted line) and specific (solid line) binding were obtained from a representative matched pair (SHRJWKY rat) of VSMC isolates. Binding parameters obtained from five matched pairs of VSMC isolates are summarized in
. Immunoblot analysis of protein kinase C (PK-C) in quiescent vascular smooth muscle cells (VSMCs) extracts. Experimental procedures have been detailed under Materials and Methods. Identical amounts (50 tig) of cell extracts from two different SHR VSMC isolates (lanes B and D) and their matched WKY rat VSMC isolates (lanes C and E) were loaded for sodium dodecyl sulfate (SDS) gel (10%) electrophoresis. Rainbow molecular weight markers (Amersham) were coelectrophoresed to facilitate determination of the molecular weight (80 kDa) of immunoreactive PK-C on immunoblots and their relative positions indicated with arrows (myosin 200 kDa, phosphorylase 92.5 kDa, albumin 69 kDa, and ovalubumin 46 kDa). SDS sample buffer only was loaded into lane A and the area corresponding to 80 kDa was also excised and counted to control for nonspecific m I binding to nitrocellulose membranes.
(SHR and WKY rats) of VSMCs when cultured under normal growth (10% FCS) conditions. Quantitatively, the amounts of [ 41 TPA and a variety of growth factors that stimulate phosphoinositide hydrolysis and diacylglycerol formation induce translocation of PK-C from the cytosol to membranes, and this is believed to reflect intracellular activation of the enzyme.
42
- 43 To investigate whether Ang II can promote PK-C translocation VSMCs were rendered quiescent before exposure to this vasoconstrictor. In such quiescent VSMCs, the subcellular distribution of [ 
Activation of S6 Kinase
S6 kinase activation can be mediated by both PK-C and intrinsic receptor tyrosine-kinase coupled pathways. 8 -18 Ang II and TPA elicit activation of S6 kinase by PK-C-independent and -dependent mechanisms, respectively. 8 The S6 kinase response to Ang II and TPA was examined in quiescent SHR- and WKY rat-derived VSMCs ( Figure 5 ). Activation of S6 kinase in response to TPA was comparable between the two cell types ( Figure 5B ). On the other hand, VSMCs from SHR exhibited an exaggerated S6 kinase activation in response to Ang II compared with WKY rat-derived VSMCs, but this did not involve an altered affinity (half-maximalry effective concentration 5 nM) for Ang II ( Figure  5A ). These data would indicate that the PK-C-dependent pathway for S6 kinase activation (by TPA) is comparable between SHR and WKY rat VSMCs, whereas differences between the two cell types are evident for the PK-C-independent pathway of S6 kinase stimulation. Although S6 kinase activation (polysome formation) is dependent on alkalinization, it is most sensitive to conditions that increase pH ( by A 0.2 units in that further alkalinization does not significantly increase polysome formation. 39 - 40 Thus, the present data demonstrating comparable S6 kinase activation (-4 pmol PO 4 incorporated/10 6 cells) for quiescent VSMCs (SHR and WKY rats) stimulated by 10% FCS (see data under Materials and Methods) or 10" 7 M TPA ( Figure 5B ) and for SHR VSMCs stimulated by 10" 7 M Ang II ( Figure 5A ) are consistent with the data on pHj (Table 1) WKY rat VSMCs exposed to 10" 7 M Ang II, the smaller pH, increase (A 0.06) was not unexpectedly associated with a lesser extent of S6 kinase activation (~2 pmol PO 4 incorporated/10 6 cells) ( Table 1 and Figure 5A ). 19 that, in this study, were found to be amplified in SHR-derived VSMCs compared with WKY rat-derived VSMCs. Our observations agree with other preliminary studies reporting greater Ang II-induced changes in pH, (using the fluorescent probe BCECF) in passaged aortic VSMCs from 10-12-week-old SHR, 25 and increased Ang II-stimulated inositol phosphate accumulation in primary cultures of aortic VSMCs from adult SHR. 23 In these studies, the increase in intracellular Ca 2+ (assessed either by fura-2 25 or 45 Ca 2+ uptake 23 ) in response to Ang II was also enhanced in SHR VSMCs compared with WKY rat VSMCs. One other study (using quin-2) failed to demonstrate an increased Ca response to Ang II. 44 The Ca 2+ response of VSMCs to Ang II is mediated both by inositol trisphosphate-promoted release of Ca 2+ from intracellular stores 45 and Ca 2+ entry through receptoroperated Ca 2+ channels. 46 There is much evidence to indicate that receptor-operated Ca 2+ channels are altered in SHR vessels (see Reference 47 for review), and this together with our observation of increased inositol trisphosphate formation in response to Ang II could account for the above findings 23 - 25 with respect to an increased intracellular Ca response in SHR VSMCs.
Enhanced phosphoinositide responsiveness to Ang II may reflect altered Ang II receptor properties. However, Schiffrin et al 48 have demonstrated vascular Ang II receptors (in mesenteric vessels) to be different between SHR and WKY rats only at the prehypertensive (4-6 weeks) phase (increased number in SHR) and not in older (12 weeks, with development of high blood pressure in SHR) rats. Differences in affinity for Ang II were not evident at any time. It has been hypothesized that the increased vascular reactivity of SHR to Ang II during the established phase of hypertension depends on postreceptor mechanisms. Increased phospholipase C activity has been reported in various tissues of SHR including the arterial wall, 49 erythrocytes, 50 and platelets. 51 Such an aberration could account for our present findings with respect to phosphoinositide metabolism. An alternative explanation may reside in changes at the level of guanine nucleotide binding (G) proteins since these are believed to couple phospholipases to receptors or to regulate phospholipase C activity. 52 However, associations between hypertension and alterations in G proteins cannot presently be made because of a relative paucity of definitive information concerning the specificity of G protein involvement in agonistinduced transmembrane signalling. 52 The greater change in pHj in stimulated SHR VSMCs (vs. WKY rat VSMCs) may reflect enhanced activation of Na + -H + exchange in these cells as proposed by Berk 53 we cannot exclude the possibility of nonparallel relations between PK-C activity and either phorbol binding or immunoreactive peptide. Nevertheless, the dose-dependent activation of S6 kinase by TPA did not differ significantly between SHR and WKY rat VSMCs, thus indicating comparable sensitivities of PK-C to phor-bol ester. Such data would imply equivalent PK-C-mediated activation of Na + -H + exchange in both VSMC isolates. However, TPA-, Ang II-, and serum-induced alkalinization were all significantly greater for SHR VSMCs, suggesting that increased Na + -H + exchange in these cells is not solely dependent on direct activation by PK-C but could also involve either some process distal to activation of this enzyme or some moiety of the Na + -H + antiporter itself. Moreover, Berk et al 38 have clearly demonstrated that Na + -H + exchange in VSMCs can be stimulated by both PK-C-dependent and PK-C-independent pathways.
There is ample evidence documenting association between cytosol to membrane translocation of PK-C and its intracellular activation. 4 PK-C is not necessarily involved in mediating the observed differential (SHR vs. WKY rats) pH, and S6 kinase activation responses to Ang II.
An intrinsic Ang II-receptor kinase activity, analogous to that of growth factor and other hormone receptors, has been postulated to account for the PK-C-independent effects of Ang II on Na + -H + exchange.
38
- 54 The amiloride sensitivity of Ang IIinduced S6 kinase activation, 8 together with the fact that phosphorylation of S6 kinase itself is necessary for enzyme activity, 18 also invokes the possibility of intrinsic receptor kinase activity in mediating PK-C-independent S6 kinase activation responses to Ang II. At present, there is no real evidence for intrinsic Ang II-receptor kinase activity, but such a postulate is quite plausible given that some growth factors (e.g., epidermal growth factor and plateletderived growth factor) have now been found to induce vasoconstriction 6 whereas not only Ang II but also vasopressin and catecholamines can exert trophic actions on cultured VSMCs (reviewed in Reference 55). Alternative processes controlling Na + -H + exchange (and thus S6 kinase because of its dependence on alkalinization for activation 8 ) include transmethylation and those pathways linked to Ca 2+ calmodulin or guanosine triphosphate binding proteins. 20 The increased Ang II-induced S6 kinase activation response in SHR VSMCs (vs. WKY rat VSMCs) may be an important mechanism for VSMC hypertrophy in hypertension. Activation of S6 kinase is an essential event for the reactivation of protein synthesis and subsequent DNA synthesis 18 23 may thus be a consequence of their greater S6 kinase activation response to Ang II. Nevertheless, the influence of Ang II on VSMC proliferation remains unclear. In our laboratory, Ang II alone (under serum-free conditions) did not exert mitogenic effects, as assessed by cellular numeration or nuclear labelling, in VSMCs from either SHR 8 or WKY rats (unpublished observation). On the other hand, Ang II has been reported either to increase VSMC size, but not cell number, 25 or to increase VSMC number to a greater extent in SHR than WKY rats. 23 It is not clear from either of these reports 23 - 25 whether VSMCs had been rendered quiescent before experimentation or whether the effects of Ang II were determined under serum-free conditions. This study provides further evidence to support enhanced metabolic responsiveness to Ang II in hypertension. Amplified pH|, phosphoinositide, and S6 kinase activation in VSMCs are likely to significantly influence both contractile and growth responses of the vasculature. Although PK-C is undoubtedly an important mediator of these biological responses, the data presented strongly suggest that deregulation of agonist-induced intracellular responses in VSMCs from SHR is unlikely to directly involve PK-C.
